Top compounds associated with response to VLDLR


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.003
mRNA BRD-K33199242 CTRPv2 pan-cancer AAC 0.12 0.003
mRNA ABT-888 CTRPv2 pan-cancer AAC 0.11 0.003
mRNA CHEMBL374350 CTRPv2 pan-cancer AAC 0.12 0.003
mRNA nelarabine CTRPv2 pan-cancer AAC 0.12 0.003
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.003
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.094 0.004
mRNA tubastatin A GDSC1000 pan-cancer AAC 0.093 0.004
mRNA lenalidomide FIMM pan-cancer AAC -0.48 0.004
mRNA AZD-2281 CTRPv2 pan-cancer AAC 0.1 0.004
Download CSV